NO971643D0 - Eter liptid-liposomer og terapeutisk anvendelse derav - Google Patents

Eter liptid-liposomer og terapeutisk anvendelse derav

Info

Publication number
NO971643D0
NO971643D0 NO971643A NO971643A NO971643D0 NO 971643 D0 NO971643 D0 NO 971643D0 NO 971643 A NO971643 A NO 971643A NO 971643 A NO971643 A NO 971643A NO 971643 D0 NO971643 D0 NO 971643D0
Authority
NO
Norway
Prior art keywords
therapeutic use
liposomes
ether lipid
lipid liposomes
phosphatidylethanolamine
Prior art date
Application number
NO971643A
Other languages
English (en)
Other versions
NO971643L (no
NO316206B1 (no
Inventor
Eric Mayhew
Andrew Stuart Janoff
Imran Ahmad
Suresh K Bhatia
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of NO971643D0 publication Critical patent/NO971643D0/no
Publication of NO971643L publication Critical patent/NO971643L/no
Publication of NO316206B1 publication Critical patent/NO316206B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NO19971643A 1994-10-14 1997-04-10 Eterlipid-liposomer og farmasöytiske sammensetninger av disse NO316206B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32304294A 1994-10-14 1994-10-14
PCT/US1995/012721 WO1996011670A1 (en) 1994-10-14 1995-10-12 Ether lipid liposomes and their therapeutic use

Publications (3)

Publication Number Publication Date
NO971643D0 true NO971643D0 (no) 1997-04-10
NO971643L NO971643L (no) 1997-06-09
NO316206B1 NO316206B1 (no) 2003-12-29

Family

ID=23257529

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19971643A NO316206B1 (no) 1994-10-14 1997-04-10 Eterlipid-liposomer og farmasöytiske sammensetninger av disse

Country Status (15)

Country Link
US (1) US5762958A (no)
EP (1) EP0785773B1 (no)
JP (1) JPH10507450A (no)
KR (1) KR100381449B1 (no)
AT (1) ATE198419T1 (no)
AU (1) AU707414B2 (no)
CA (1) CA2199179A1 (no)
DE (1) DE69519802T2 (no)
DK (1) DK0785773T3 (no)
ES (1) ES2153053T3 (no)
FI (1) FI971494A0 (no)
GR (1) GR3035689T3 (no)
NO (1) NO316206B1 (no)
PT (1) PT785773E (no)
WO (1) WO1996011670A1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007839A (en) * 1996-02-16 1999-12-28 The Liposome Company, Inc. Preparation of pharmaceutical compositions containing etherlipid-containing multiple lipid liposomes
US5965159A (en) * 1996-02-16 1999-10-12 The Liposome Company, Inc. Etherlipid-containing multiple lipid liposomes
USRE39042E1 (en) * 1996-02-16 2006-03-28 The Liposome Company, Inc. Etherlipid-containing multiple lipid liposomes
US5942246A (en) * 1996-02-16 1999-08-24 The Liposome Company, Inc. Etherlipid containing multiple lipid liposomes
US6667053B1 (en) 1996-02-16 2003-12-23 Elan Pharmaceuticals, Inc. D and L etherlipid stereoisomers and liposomes
US5932242A (en) * 1996-10-15 1999-08-03 The Liposome Company, Inc. Ether lipid-containing pharmaceutical compositions and therapeutic uses thereof
DE19829448A1 (de) * 1998-07-01 2000-10-12 Medmark Pharma Gmbh 1-Octadecyl-2-methyl-sn-glycero-3-phosphocholin (ET180CH3) zur Behandlung von humanen Mammakarzinomen
ES2154560B1 (es) * 1998-09-16 2001-12-01 Lipotec Sa Composicion a base de derivados de cromanos y su uso para reducir quimicamente las reacciones oxidativas o inducidas por radicales libres.
JP2002532553A (ja) * 1998-12-21 2002-10-02 インケイサ．ソシエダ アノニマ 有害な胃腸副作用を引き起こさない有力な抗炎症剤としてのエーテルリゾリン脂質の使用
US7772196B2 (en) 2000-01-10 2010-08-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases
US7608598B2 (en) 2000-01-10 2009-10-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of conjunctivitis
US7893226B2 (en) 2004-09-29 2011-02-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Use of lipid conjugates in the treatment of diseases
US8916539B2 (en) 2000-01-10 2014-12-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of disease
US9040078B2 (en) 2000-01-10 2015-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases of the nervous system
US8304395B2 (en) 2000-01-10 2012-11-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Lipid conjugates in the treatment of disease
US8501701B2 (en) 2000-01-10 2013-08-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Use of lipid conjugates in the treatment of disease
US8076312B2 (en) 2000-01-10 2011-12-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Use of lipid conjugates in the treatment of disease
US8883761B2 (en) 2001-01-10 2014-11-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases associated with vasculature
DK1827379T3 (da) 2004-10-19 2011-04-04 Mpg Max Planck Ges Zur Foerderung Der Wissenschaften E V Formuleringer med alkylphosphocholiner under anvendelse af nye negative ladningsbærere
CA2587883A1 (en) * 2004-11-17 2006-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusale M Use of polymer-lipid conjugates in the prevention and treatment of chronic pulmonary disease, allergic rhinitis and asthma
JP2006248978A (ja) * 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
US8906882B2 (en) 2005-11-17 2014-12-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Lipid conjugates in the treatment of allergic rhinitis
US8859524B2 (en) 2005-11-17 2014-10-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Lipid conjugates in the treatment of chronic rhinosinusitis
DE102006019907A1 (de) * 2006-04-28 2007-10-31 Müller-Enoch, Dieter, Prof. Dr. Verwendung von substituierten Glycerinderivaten zur Herstellung einer pharmazeutischen Zubereitung
CA2705785A1 (en) 2006-11-14 2008-05-22 Saul Yedgar Use of lipid conjugates in the treatment of diseases or disorders of the eye
US8637688B2 (en) * 2006-12-20 2014-01-28 Julia Diederichs Topical dosage form comprising tri-substituted glycerol compounds
EP2536414B1 (en) 2010-02-18 2016-07-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for preventing cancer metastasis
US20150132369A1 (en) * 2013-11-09 2015-05-14 Exir Nano Sina Company Nanoliposomal cyclosorin formulations for immunosuppresion and methods for the production thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2009343C3 (de) * 1970-02-27 1980-10-23 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Verwendung von Lysolecithinen als immunologische Adjuvantien
US4163748A (en) * 1973-09-06 1979-08-07 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Propane-1,3-diol phosphatides and method of preparing the same
US4159988A (en) * 1974-08-06 1979-07-03 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Synthetic phospholipids, a process for their manufacture and their use
DE2619686C2 (de) * 1976-05-04 1986-08-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verwendung eines Lysolecithins zur Tumorbehandlung
DE3011738A1 (de) * 1980-03-26 1981-10-01 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue glycerin-3-phosphorsaeurehalogenalkylester
DE3239858A1 (de) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue d-mannitderivate als ausgangsprodukte zur synthese von phospholipiden
JPS5972294A (ja) * 1982-10-18 1984-04-24 Hisaji Nakamura スピ−カ装置
PH26160A (en) * 1985-08-19 1992-03-18 Univ Texas Pharmaceutical compositions consisting of acylated phospholipids
US4983397A (en) * 1985-08-19 1991-01-08 Board Of Regents, University Of Texas System Pharmaceutical compositions consisting of acylated phospholipids
US4920016A (en) * 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
US4965391A (en) * 1987-10-23 1990-10-23 The University Of Michigan Radioiodinated phospholipid ether analogues
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
DE4111105A1 (de) * 1991-04-05 1992-10-08 Max Planck Gesellschaft Neue erucyl-, brassidyl- und nervonylderivate
US5277913A (en) * 1991-09-09 1994-01-11 Thompson David H Liposomal delivery system with photoactivatable triggered release
DE4132345A1 (de) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Ether-lysolecithine und alkylphosphocholine in liposomen
EP0610289B1 (en) * 1991-10-23 1997-08-06 National Research Council Of Canada Formation of stable liposomes from lipid extracts of archaeobacteria (archaea)
KR960702297A (ko) * 1993-05-21 1996-04-27 카롤 질레스피 리포좀 유도된 불리한 생리학적 반응감소 (reduction of liposome-induced adverse physiological reactions)
DE4408011C1 (de) * 1994-03-10 1995-11-02 Max Delbrueck Centrum Pharmazeutisches Mittel zur Tumortherapie

Also Published As

Publication number Publication date
CA2199179A1 (en) 1996-04-25
WO1996011670A1 (en) 1996-04-25
ATE198419T1 (de) 2001-01-15
AU3762595A (en) 1996-05-06
EP0785773B1 (en) 2001-01-03
JPH10507450A (ja) 1998-07-21
FI971494A (fi) 1997-04-10
PT785773E (pt) 2001-05-31
KR970705378A (ko) 1997-10-09
EP0785773A1 (en) 1997-07-30
KR100381449B1 (ko) 2003-07-18
NO971643L (no) 1997-06-09
GR3035689T3 (en) 2001-07-31
AU707414B2 (en) 1999-07-08
US5762958A (en) 1998-06-09
DE69519802T2 (de) 2001-04-19
FI971494A0 (fi) 1997-04-10
DE69519802D1 (de) 2001-02-08
NO316206B1 (no) 2003-12-29
ES2153053T3 (es) 2001-02-16
DK0785773T3 (da) 2001-01-29

Similar Documents

Publication Publication Date Title
NO971643D0 (no) Eter liptid-liposomer og terapeutisk anvendelse derav
ES2186792T3 (es) Metodos de fabricar liposomas que contienen fotosensibilizantes hidro-monobenzoporfirinicos.
GR1000074B (el) Λιποειδη σφαιριδια (κυστιδια) για ενδοπεριτονειακη χορηγηση θεραπευτικων παραγοντων.
ES2194114T3 (es) Formulaciones liposomicas de mitoxantrona.
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
DE69508598D1 (de) Mit polyethylenglycol modifizierte ceramidlipide und liposomen
FI843930L (fi) Maerkta konjugat av metalltionein och maolsoekande biologiskt aktiva molekyler.
DE69835692D1 (de) Geladene lipide und deren verwendung
TR200100868T2 (tr) Indeno-,nafto-, benzosiklohepta-dihidrotiyazol türevleri, imalatları, anorektal ilaç olarak kullanılmaları.
DE69324367T2 (de) Kationische lipide
PT758248E (pt) Formulacoes para o factor ix
TR199700872A3 (tr) Kompleks lipid' lerin kullanilmasi.
ES2142030T3 (es) Nuevos compuestos espiro-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2041617T3 (es) Productos intermedios para agentes de quelacion con simetria prefijada y procedimiento para su preparacion.
JPS6471881A (en) Tetracyclic quinazoline derivative, manufacture and use
DK619484D0 (da) Farmaceutisk praeparat mod rheumatiske lidelser
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання
IT1251840B (it) Uso di formulazioni liposomiali contenenti papaverina nel trattamento della impotenza maschile
ITMI950729A0 (it) Uso della lisofosfatidilcolina nel campo della riproduzione umana
ITMI940414A0 (it) Procedimento per la coniugazione di proteine di interesse terapeutico o diagnostico
TH18330B (th) อนุพันธ์กรดไขมัน
UA36920A (uk) Спосіб лікування хронічного катарального гінгівіту у дітей
BR6700746U (pt) Aparelho eletrico para tratamento dos orgaos sexuais masculinos
ITBO940487A0 (it) Attrezzo per la ginnastica ribaltativa da letto di degenti
DE9405769U1 (de) Verbindungsstück für Puppenhochstuhl